Immune related adverse events to immune checkpoint inhibitors
Pathology. 2017;49:S46 
38351 Immune-related adverse events in cancer patients receiving immune checkpoint inhibitors
Journal of Clinical and Translational Science. 2021;5(s1):116-117
Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
Clinical Infectious Diseases. 2019;70(7):1519-1519
Immune-Related Adverse Events From Immune Checkpoint Inhibitors
Clinical Pharmacology & Therapeutics. 2016;100(3):242-251
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
International Journal of Cancer. 2019;145(3):639-648
Evaluation of the Reporting of Safety and Immune-Related Adverse Events in Clinical Trials of FDA-Approved Immune Checkpoint Inhibitors in Oncology
. 2020;
The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
. 2020;
The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
. 2020;
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Immune Network. 2020;20(1):
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
Current Rheumatology Reports. 2018;20(10):